1. Levav, I. & Rutz, W. (2002). The WHO, World Health Report 2001 new understanding-new hope. The Israel Journal of Psychiatry and Related Sciences, 39(1), 50–56.
2. Bulletin épidémiologique hebdomadaire. (n.d.). Article. Retrieved March 10, 2023, from http://beh.santepubliquefrance.fr/beh/2018/32-33/2018_32-33_1.html
3. Hardeveld, F., Spijker, J., De Graaf, R., Nolen, W. A. & Beekman, A. T. F. (2010). Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatrica Scandinavica, 122(3), 184–191. https://doi.org/10.1111/j.1600-0447.2009.01519.x
4. American Psychiatric Association. (n.d.). Critères de diagnostic de l’épisode dépressif caractérisé selon le DSM-5, 1.
5. HAS. Recommandation 2009. Trouble dépressif récurrent. (n.d.). Retrieved from https://www.has-sante.fr/upload/docs/application/pdf/2009-04/gm_ald23_t…
6. Gaillard, A. (n.d.). Dépression et récurrences.
7. Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., … Schatzberg, A. F. (2006). Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder. Neuropsychopharmacology, 31(9), 1841–1853. https://doi.org/10.1038/sj.npp.1301131
8. Lam, R. W., McIntosh, D., Wang, J., Enns, M. W., Kolivakis, T., Michalak, E. E., … Ravindran, A. V. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 61(9), 510–523. https://doi.org/10.1177/0706743716659416
9. Buckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D., Fearon, P. & Pilling, S. (2018). Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis. Clinical Psychology Review, 64, 13–38. https://doi.org/10.1016/j.cpr.2018.07.005
10. Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., … Uher, R. (2016). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments. The Canadian Journal of Psychiatry, 61(9), 540–560. https://doi.org/10.1177/0706743716659417
11. Guidi, J., Tomba, E. & Fava, G. A. (2016). The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature. American Journal of Psychiatry, 173(2), 128–137. https://doi.org/10.1176/appi.ajp.2015.15040476
12. Chen, H., He, Q., Wang, M., Wang, X., Pu, C., Li, S. & Li, M. (2022). Effectiveness of CBT and its modifications for prevention of relapse/recurrence in depression: A systematic review and meta-analysis of randomized controlled trials. Journal of Affective Disorders, 319, 469–481. https://doi.org/10.1016/j.jad.2022.09.027
Étude et pratique
HTA : quelle PA cible chez les patients à haut risque cardiovasculaire ?
Mise au point
Troubles psychiatriques : quand évoquer une maladie neurodégénérative ?
Étude et pratique
Complications de FA, l’insuffisance cardiaque plus fréquente que l’AVC
Cas clinique
L’ictus amnésique idiopathique